In prostate cancer, PTBP1 was known to affect the clinical response to Androgen-deprivation therapy [36], indicting PTBP1 plays vitally regulatory roles in clinical cancer diagnosis and treatment. The gene discussed is PTBP1; the disease is prostate carcinoma.